Tatiana. Age: 30.
Transgender hormone therapy of the male-to-female MTF type, also known as feminizing hormone therapyis hormone therapy and sex reassignment therapy to change the secondary sexual characteristics of transgender people from masculine or androgynous to feminine. Some intersex people also take this form of therapy, according to their personal needs and preferences. The purpose of the therapy is to cause the development of the secondary sex characteristics of the desired sexsuch as breasts and a feminine pattern of hairfatand muscle distribution. It cannot undo many of the changes produced by naturally occurring pubertywhich may necessitate surgery and other treatments to reverse see below.
Addison. Age: 29.
Transgender women are individuals who were assigned male at birth but who have a female or feminine gender identity. Although not all transfeminine individuals have a desire to undergo a medical or surgical gender transition, many do. Often, the first step in a medical gender transition is to begin cross-sex hormone therapy.
Kaylee. Age: 21.
Testosterone Blockers Options for Transgender Women
Current Opinion in Endocrinology, Diabetes and Obesity 20 6 : Endocr Pract ; — A cross-sectional study.
Transitioning refers to any physical, mental, or emotional change that a person makes in order to better reflect their gender identity. Some transgender people identify as neither male nor female, or as a combination of male and female. Everyone—transgender or not—has a gender identity. As transgender people, we make many choices about transitioning, and continue making choices over our lifetimes.